Hainan Poly Pharm Co Ltd (300630) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.015x

Based on the latest financial reports, Hainan Poly Pharm Co Ltd (300630) has a cash flow conversion efficiency ratio of 0.015x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.82 Million ≈ $6.56 Million USD) by net assets (CN¥3.01 Billion ≈ $440.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hainan Poly Pharm Co Ltd (300630) total market value for the company's overall valuation and market capitalisation.

Hainan Poly Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2023)

This chart illustrates how Hainan Poly Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hainan Poly Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Poly Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Hainan Poly Pharm Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tridomain Performance Materials PT JK:TDPM	0.076x
Kelly Services B Inc NASDAQ:KELYB	0.050x
Sab Zenzele Kabili Holdings JSE:SZK	0.020x
XXL ASA OL:XXL	-0.085x
Tamawood Ltd AU:TWD	0.257x
AEC SECURITIES BK:BYD-R	N/A
LUOYANG GLASS CO. H YC 1 F:LUG	N/A
Home Federal Bancorp Louisiana NASDAQ:HFBL	-0.022x

Annual Cash Flow Conversion Efficiency for Hainan Poly Pharm Co Ltd (2016–2023)

The table below shows the annual cash flow conversion efficiency of Hainan Poly Pharm Co Ltd from 2016 to 2023. View latest Hainan Poly Pharm Co Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	CN¥2.91 Billion ≈ $425.27 Million	CN¥112.72 Million ≈ $16.49 Million	0.039x	-79.66%
2022-12-31	CN¥2.80 Billion ≈ $410.10 Million	CN¥534.29 Million ≈ $78.18 Million	0.191x	+208.59%
2021-12-31	CN¥2.54 Billion ≈ $371.94 Million	CN¥157.03 Million ≈ $22.98 Million	0.062x	-62.06%
2020-12-31	CN¥2.04 Billion ≈ $298.39 Million	CN¥332.08 Million ≈ $48.59 Million	0.163x	-13.35%
2019-12-31	CN¥1.15 Billion ≈ $167.69 Million	CN¥215.37 Million ≈ $31.52 Million	0.188x	+75.14%
2018-12-31	CN¥883.26 Million ≈ $129.25 Million	CN¥94.79 Million ≈ $13.87 Million	0.107x	-17.46%
2017-12-31	CN¥721.37 Million ≈ $105.56 Million	CN¥93.79 Million ≈ $13.72 Million	0.130x	-28.09%
2016-12-31	CN¥307.12 Million ≈ $44.94 Million	CN¥55.53 Million ≈ $8.13 Million	0.181x	--

About Hainan Poly Pharm Co Ltd

SHE:300630 China Drug Manufacturers - Specialty & Generic

Market Cap

$73.10 Million

CN¥499.57 Million CNY

Market Cap Rank

#20504 Global

#4682 in China

Share Price

CN¥0.89

Change (1 day)

+0.00%

52-Week Range

CN¥0.89 - CN¥0.89

All Time High

CN¥70.54